Stock Events

Stock Events

Imricor Medical Systems 

A$1.3000
7
-A$0.05-3.7% 04:55 Today

Statistics

Day High
1.36
Day Low
1.245
52W High
2.25
52W Low
1.245
Volume
316,541
Avg. Volume
817,676
Mkt Cap
417.23M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

Aug 22Expected
Q3 2022
Q4 2022
Q3 2023
Q4 2023
Q2 2024
999
333
-333
-999
Expected EPS
N/A
Actual EPS
N/A

Financials

-8,651.83%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
441,960.62Revenue
-38.24MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow IMR.AU. It's not an investment recommendation.
Commonwealth Bank of Australia
4
CBA.AU
National Australia Bank Limited
4
NAB.AU
Westpac Banking
3
WBC.AU
PLS Group
3
PLS.AU

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Medtronic
MDT
Mkt Cap123.49B
Medtronic is a major player in the medical device sector, specifically in cardiovascular and cardiac rhythm management, directly competing with Imricor's MRI-compatible cardiac ablation products.
Abbott Laboratories
ABT
Mkt Cap183.77B
Abbott Laboratories offers a range of medical devices, including cardiac rhythm management products, competing in the same space as Imricor.
Boston Scientific
BSX
Mkt Cap60.84B
Boston Scientific competes with Imricor in the interventional cardiology market, particularly in areas involving cardiac procedures and electrophysiology.
Johnson & Johnson
JNJ
Mkt Cap657.68B
Johnson & Johnson, through its medical devices segment, competes in the cardiovascular and electrophysiology market, overlapping with Imricor's product offerings.
Siemens
SIEGY
Mkt Cap239.92B
Siemens Healthineers offers a wide range of medical imaging and diagnostic equipment, including MRI systems that are used in cardiac procedures, competing indirectly with Imricor.
GE Aerospace
GE
Mkt Cap313.14B
General Electric, through GE Healthcare, provides medical imaging and MRI equipment used in various medical procedures, including those for cardiac care, competing indirectly with Imricor.
Koninklijke Philips N.V.
PHG
Mkt Cap26.31B
Philips, a leader in health technology, provides advanced MRI systems and related healthcare solutions that are used in cardiac imaging and interventions.
Biosyent
BIOYF
Mkt Cap116.49M
Biotronik is known for its innovations in cardiac rhythm management and electrophysiology, directly competing with Imricor in these niche areas.

About

Imricor Medical Systems, Inc., a medical device company, designs, manufactures, sells, and distributes magnetic resonance imaging (MRI) compatible products for cardiac catheter ablation procedures in the United States, Europe, and the Middle East. The company’s products include Vision-MR Ablation Catheter 2.0, a MR-compatible cardiac ablation catheter; Vision-MR Diagnostic Catheter, a MR-compatible diagnostic catheter; NorthStar mapping system, a real-time, high-resolution soft tissue imaging of MRI to guide and visualize procedures with exceptional clarity; and Advantage-MR EP Recorder / Stimulator. It also offers Vision-MR Dispersive Electrode to minimize eddy currents induced on the device’s conductive pads during mr scanning. Imricor Medical Systems, Inc. was incorporated in 2006 and is headquartered in Burnsville, Minnesota.
Show More
CEO
Steven Wedan
Employees
78
Country
United States
ISIN
AU0000054942
WKN
000A2PRSP

Listings

AU
AU
IMR.AU
F
DE
M89.F

0 Comments

Share your thoughts

FAQs

What is Imricor Medical Systems stock price today?▼
The current price of IMR.AU is A$1.30 AUD — it has decreased by -3.7% in the past 24 hours. Watch Imricor Medical Systems stock price performance more closely on the chart.
What is Imricor Medical Systems stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Australia Exchange exchange Imricor Medical Systems stocks are traded under the ticker IMR.AU.
Is Imricor Medical Systems stock price growing?▼
IMR.AU stock has fallen by -2.26% compared to the previous week, the month change is a -13.62% fall, over the last year Imricor Medical Systems has showed a -8.77% decrease.
What is Imricor Medical Systems market cap?▼
Today Imricor Medical Systems has the market capitalization of 417.23M
What is Imricor Medical Systems revenue for the last year?▼
Imricor Medical Systems revenue for the last year amounts to 441,960.62 AUD.
What is Imricor Medical Systems net income for the last year?▼
IMR.AU net income for the last year is -38.24M AUD.
How many employees does Imricor Medical Systems have?▼
As of November 2, 2026, the company has 78 employees.
In which sector is Imricor Medical Systems located?▼
Imricor Medical Systems operates in the Health & Wellness sector.
When did Imricor Medical Systems complete a stock split?▼
Imricor Medical Systems has not had any recent stock splits.
Where is Imricor Medical Systems headquartered?▼
Imricor Medical Systems is headquartered in Burnsville, United States.